India's stock exchange lists itself, and its quiet debut is a lesson for startup exits
The National Stock Exchange of India opened less than 1% above its offer price on Thursday. The muted start says more about how public investors now price growth than about the exchange itself.
The National Stock Exchange of India, the venue on which most of the country's equity trading takes place and where a generation of Indian startups hopes eventually to list, became a public company itself on Thursday, September 24. Its shares opened at ₹1,800 on BSE, its older rival and the designated exchange for the offer, a premium of about 0.84% to the ₹1,785 issue price. Within an hour the stock had risen more than 5%, briefly lifting the exchange's market value to ₹4.64 lakh crore, and by 12:33 pm it was trading at ₹1,843.40, up 3.27%.
For a listing that had been talked about for a decade, the opening was strikingly calm. The offer was large, at up to ₹22,561.57 crore, and it was covered 5.71 times. Yet the first print landed below what grey market dealers had been signalling. That gap between demand in the book and enthusiasm on the screen is the most useful thing the debut tells founders and investors who are counting on public markets to return capital in the next two years.
A sale by long-term holders, not a capital raise
The structure matters. The issue was a pure offer for sale of 12.64 crore shares, with no fresh issue, so the exchange received nothing. Every rupee went to existing shareholders. State Bank of India was the largest seller named in the offer documents, with up to roughly 1.60 crore shares, followed by Canada Pension Plan Investment Board with up to 1.19 crore and Aranda Investments (Mauritius) with up to 1.12 crore. Public sector insurers and Bank of Baroda also sold. Life Insurance Corporation of India, which holds 10.72%, chose to keep its entire stake.
The disclosed acquisition costs illustrate what an exit at this scale means. SBI's weighted average cost was ₹0.80 per share. Canada Pension Plan, a later and more expensive entrant, carried an average cost of ₹324.13, which means it sold at roughly 5.5 times its basis. Those are the kind of multiples private investors in Indian technology companies have been promising their own limited partners, and they were realised here through an asset that is profitable, dominant and has no identifiable promoter.
What the price says about the asset
At the issue price the exchange was valued at about 43 times its earnings for the year to March 2026, according to Finance Outlook India. Its market value at the open, around ₹4.45 trillion, was almost double the combined worth of BSE, MCX and IEX, the other listed Indian exchange operators. Value Add VC put the figure at about $46 billion.
The financial record behind that valuation is strong but not uniformly rising. Revenue from operations was ₹16,601.31 crore in FY26 against ₹17,140.68 crore a year earlier, a decline of about 3%. Profit after tax fell to ₹10,302.06 crore from ₹12,187.69 crore, roughly 15% lower. EBITDA still came to about two thirds of revenue, a margin few listed businesses anywhere can match.
Concentration is the obvious risk. Options transaction charges accounted for more than 60% of operating revenue in FY26, and those fees depend on trading volumes and on how the regulator chooses to treat retail derivatives. The exchange's market share is close to total: about 93% of cash market turnover and nearly 100% of equity futures in FY26. Investors therefore bought a near-monopoly, but one whose earnings already dipped once and whose largest revenue line sits at the discretion of policy makers.
The subscription pattern reflects that judgement. Qualified institutional buyers bid for 12.68 times the shares reserved for them and non-institutional investors 6.55 times, while retail demand reached only 1.39 times. Professionals wanted the stock at a fair price. Households, who drive the options volumes that fill the exchange's income statement, were far less eager to own the company itself.
A selective window, at home and abroad
The NSE result fits a wider pattern visible in the same week. Value Add VC counted roughly three dozen IPO pricings worldwide between September 20 and 26, with performance split sharply by sector and story. Ligent Technologies rose 19.2% on its Hong Kong debut on demand for AI infrastructure. Electra Therapeutics fell 12% on its first day despite pricing at the midpoint of its range. ADARx Pharmaceuticals priced an upsized offering at the top of its range, at $17 a share.
In New York, two listings were pulled. Holtec Nuclear postponed its IPO citing market conditions, and earlier this week Bamboo Insurance Services, a Utah home insurer controlled by CVC-advised funds, postponed a listing that had been marketed as an all secondary offering at $18 to $20 a share. According to Bloomberg data reported by Insurance Journal, US IPOs have raised $161.4 billion this year, the highest volume since 2021, but five of the ten largest 2026 listings were trading below their offer prices and the year's deals had returned a weighted average of 13%, against roughly 15% for the S&P 500.
The common thread is that public investors are paying for proven economics and are wary of selling shareholders who want a full price on the way out. Bamboo's offer, like NSE's, would have raised no money for the company. One cleared with a muted debut, the other did not clear at all.
Why Indian startups should pay attention
India's venture-backed companies have been leaning heavily on the domestic market. Inc42 reported in January that at least 18 new-age companies raised ₹41,283 crore from listings in 2025, and that 21 startups had filed draft papers with the Securities and Exchange Board of India, with 25 more preparing 2026 offerings. Sunny Agrawal, head of fundamental equity research at SBI Securities, told the publication that "the emphasis has moved decisively away from the growth-at-any-cost narratives."
The NSE listing is a direct test of that claim. Here was a company with about two thirds EBITDA margins, a dominant franchise and a 5.71 times oversubscribed book, and still the market declined to award it a meaningful first-day premium. Loss-making consumer platforms, whose filings rely on future margin expansion, will face the same institutional buyers with less to show.
There is also a supply effect. A sale of this size absorbs a large slice of the domestic institutional appetite for new issues in a single week. Bankers planning startup listings for the coming months will be watching whether the money that went into NSE comes back to the primary market or stays in the secondary trading of a stock that is now one of India's most valuable listed companies.
Our view
The NSE debut should be read as a success for its sellers and a warning for everyone else. Long-term holders turned stakes acquired for a few rupees into cash at a price of 43 times falling earnings, and institutions accepted those terms because the franchise is extraordinary. Few startups can offer anything comparable.
For founders, the message is that oversubscription is not the same as a premium. Books can be filled by professionals who are disciplined on price, and the first print will reflect their caution rather than the headline multiple. For venture investors, the lesson is about structure. Offers made up mostly of secondary shares are being scrutinised closely, as Bamboo found in New York this week. An IPO that also funds the company's growth gives buyers a reason to stretch.
What to watch next: how the stock trades once anchor and pre-IPO lock-ups approach, whether Indian regulators change the rules on retail options that drive most of the exchange's revenue, and whether the startups that filed draft papers this year move ahead or wait.
Sources
- Groww: NSE shares list at 0.8% premium on BSE
- Kotak Neo: NSE IPO listing, shares list at a modest premium
- Finance Outlook India: NSE market debut makes exchange one of India's most valuable companies
- Asianet Newsable: NSE IPO, SBI largest seller, offer size up to Rs 22,561 crore
- Value Add VC: The fall 2026 IPO window, by the numbers
- Insurance Journal: Bamboo Insurance postpones IPO
- Inc42: SBI Securities sees India's new-age IPO cycle entering a more disciplined phase in 2026
Filed under Markets. Written by InvestTimes Editorial under our editorial standards. Commentary and analysis for information only, not investment advice.
